ImmunoPrecise regains Nasdaq compliance on minimum bid price

4 hours ago 1

ImmunoPrecise Antibodies (NASDAQ:IPA) has regained compliance with Nasdaq.
The company's stock maintained a closing bid price of at least $1/share for 10 consecutive business days from June 26, 2025, through July 10, 2025.
IPA shares up 2.7% premarket on Monday.
Source: Press release

Recommended For You